Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: Influence on muscle glycogen synthase and insulin receptor kinase activity
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 44 (12) , 1570-1576
- https://doi.org/10.1016/0026-0495(95)90077-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Influence of short-term dexfenfluramine therapy on glucose and lipid metabolism in obese non-diabetic patientsActa Endocrinologica, 1993
- Dexfenfluramine in the treatment of severe obesity: a placebo‐controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviourJournal of Internal Medicine, 1992
- Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patientsEuropean Journal of Clinical Pharmacology, 1992
- A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge- eatersAmerican Journal of Psychiatry, 1990
- Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance SpectroscopyNew England Journal of Medicine, 1990
- INTERNATIONAL TRIAL OF LONG-TERM DEXFENFLURAMINE IN OBESITYThe Lancet, 1989
- Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patientsDiabetes, 1989
- Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.Journal of Clinical Investigation, 1987
- Correlation between muscle glycogen synthase activity and in vivo insulin action in man.Journal of Clinical Investigation, 1984
- Hypoglycemic Action of Fenfluramine in Diabetes MellitusDiabetes, 1973